Related Experiment Video
Updated: May 3, 2026

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Src as the link between inflammation and cancer
Sandy T Liu1, Hung Pham2, Stephen J Pandol3
1Department of Medicine, Cedars-Sinai Medical Center Los Angeles, CA, USA ; Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles CA, USA.
Abstract:
Although a causal link between chronic inflammation and cancer has been established, the exact molecular mechanism linking inflammation to cancer remains largely unknown. It was previously postulated that molecular switches responsible for cancer cell development, and for infiltration of inflammatory cells into cancer, were divided into a distinct set of intracellular proteins and signaling pathways. However, recent evidence suggests that both tumor cells and tumor-infiltrating immune cells utilize the same kinases, mostly that of Src family, to facilitate cancer development and progression. In the past few years several groups have found that Src activation both in cancer and inflammatory cells is mainly driven by pro-inflammatory cytokines within the tumor microenvironment. Here we evaluate the cross talks between Src kinase pathways in immune cells and cancer cells. We conclude that Src might serve as a critical mechanistic link between inflammation and cancer, mediating and propagating a cycle between immune and tissue cells that can ultimately lead to the development and progression of cancer.
Insights
Chronic inflammation and cancer share molecular links, particularly through Src kinase pathways. This study reveals how Src kinase mediates communication between immune and cancer cells, driving cancer progression.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- A causal link between chronic inflammation and cancer is established.
- The precise molecular mechanisms connecting inflammation and cancer are not fully understood.
- Previously, distinct molecular pathways were thought to govern cancer cell development and immune cell infiltration.
Purpose of the Study:
- To investigate the crosstalk between Src kinase pathways in immune and cancer cells.
- To elucidate the role of Src family kinases in mediating the link between inflammation and cancer progression.
Main Methods:
- Evaluation of cross-talk between Src kinase pathways.
- Analysis of Src activation in cancer and inflammatory cells within the tumor microenvironment.
- Review of recent evidence on kinase utilization by tumor and immune cells.
Main Results:
- Both tumor cells and tumor-infiltrating immune cells utilize common kinases, primarily Src family kinases.
- Src activation in both cell types is driven by pro-inflammatory cytokines in the tumor microenvironment.
- Src kinase pathways exhibit significant crosstalk between immune and cancer cells.
Conclusions:
- Src kinase acts as a critical mechanistic link between inflammation and cancer.
- Src mediates a cycle between immune and tissue cells, promoting cancer development and progression.
- Targeting Src pathways may offer therapeutic strategies for inflammation-driven cancers.
Related Concept Videos
Chronic Inflammation: Introduction
Inflammation
The JAK-STAT Signaling Pathway
Inflammation: Introduction
Selectins
Acute Inflammation I: Cellular Phase

